J1598 Inj glycopyrrolate fres kabi

Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 12 units per day (practitioner), rationale: CMS Policy